Cannabis stocks rally on expectations of Trump move to ease curbs

Canopy Growth

18/12/2025 14:55

Updates

** Cannabis firms' US-listed shares rise between 5% and 20%

** President Trump expected to sign an executive order to ease restrictions on Schedule I narcotic and deem it a less dangerous drug

** Cronos Group CRON.O and Aurora Cannabis ACB.O rise 5.8% and 10%, respectively

** Tilray Brands TLRY.O jumps 15.2% and Canopy Growth CGC.O surges 17.7%

** Stocks have soared since reports emerged last week of Trump's plan to ease the curbs, which could ease reduce tax burdens and improve access to capital for the pot industry

** Currently, marijuana, along with LSD and heroin, is a Schedule I controlled substance, meaning they have no currently accepted medical use and a high potential for abuse

 (Reporting by Padmanabhan Ananthan and Siddhi Mahatole)

 ((Padmanabhan.Ananthan@thomsonreuters.com))